News

Filter

Current filters:

VertexBiotechnology

1 to 9 of 97566 results

Abbott's last quarter 2014 results come in below estimates

Abbott's last quarter 2014 results come in below estimates

29-01-2015

Currency fluctuations are a cause for concern for US health care company Abbott Laboratories, as it reports…

AbbottAbbott LaboratoriesFinancialPharmaceuticalUSA

Strong cancer drug sales boost Celgene 4th-qtr and full-year 2014 results

Strong cancer drug sales boost Celgene 4th-qtr and full-year 2014 results

29-01-2015

US biotech firm Celgene posted 2014 financials before the markets opened this morning, showing that fourth…

AbraxaneBiotechnologyCelgene CorpFinancialOncologyRevlimid

European Commission clears Mylan acquisition of Abbott's European generics business

European Commission clears Mylan acquisition of Abbott's European generics business

29-01-2015

The European Commission has cleared the proposed acquisition of Abbott Laboratories’ non-US developed…

Abbott LaboratoriesEuropeGenericsMergers & AcquisitionsMylan

Baxter says record 2014 results set solid foundation for planned separation

29-01-2015

US drugmaker Baxter International today announced fourth quarter 2014 financial results that exceeded…

Baxter InternationalFinancialPharmaceutical

Australia: Foresight to translate research into treatments, devices and diagnostics

29-01-2015

Amid the growing realization that Australian research needs support to make it a reality, the Queensland…

AustraliaBiotechnologyFinancialResearch

Phase III trial shows Novartis' Jakavi significantly improves hematocrit control

Phase III trial shows Novartis' Jakavi significantly improves hematocrit control

29-01-2015

Results from the pivotal Phase III trial of Jakavi (ruxolitinib) carried out by Swiss drug major Novartis…

HematologyJakaviNovartisPharmaceuticalResearch

GSK and Novartis get European clearance for asset swap

GSK and Novartis get European clearance for asset swap

29-01-2015

UK pharma major GlaxoSmithKline has received clearance from the European Commission for its proposed…

EuropeFinancialGlaxoSmithKlineNovartisOncologyPharmaceuticalUK

AstraZeneca to employ CRISPR, a new technique for drug discovery

AstraZeneca to employ CRISPR, a new technique for drug discovery

29-01-2015

Anglo-Swedish pharma major AstraZeneca has announced a research program to develop new medicines that…

AstraZenecaBiologyBiotechnologyResearchUK

1 to 9 of 97566 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top